​

Mustang Bio (MBIO) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

MBIO Stock Rating

Mustang Bio stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 7 Strong Sell Sell Hold Buy Strong Buy

MBIO Price Target Upside V Benchmarks

TypeNameUpside
StockMustang Bio-
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.49$1.49$1.49
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 241----1
Oct, 2411---2
Sep, 2411---2
Aug, 2411---2
Jul, 2412---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 13, 2024H.C. WainwrightBuyBuyhold
Nov 16, 2022BTIGBuyBuyhold

Financial Forecast

EPS Forecast

$-400 $-320 $-240 $-160 $-80 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-6.00$-0.03---
Avg Forecast$-365.83$-40.50$-17.50$-99.00$-51.50
High Forecast$-365.83$-40.50$-17.50$-99.00$-51.50
Low Forecast$-365.83$-40.50$-17.50$-99.00$-51.50
Surprise %-98.36%-99.93%---

Revenue Forecast

$10M $20M $30M $40M $50M $60M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported-----
Avg Forecast---$11.00M$55.60M
High Forecast---$11.00M$55.60M
Low Forecast---$11.00M$55.60M
Surprise %-----

Net Income Forecast

$-4B $-3B $-2B $-1B $-700M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$-51.60M$-15.75M---
Avg Forecast$-3.15B$-348.47M$-150.57M$-851.81M$-443.11M
High Forecast$-3.15B$-348.47M$-150.57M$-851.81M$-443.11M
Low Forecast$-3.15B$-348.47M$-150.57M$-851.81M$-443.11M
Surprise %-98.36%-95.48%---

MBIO Forecast FAQ

Is Mustang Bio stock a buy?

Mustang Bio stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Mustang Bio is a favorable investment for most analysts.

What is Mustang Bio's price target?

Mustang Bio's price target, set by 7 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.49.

How does Mustang Bio stock forecast compare to its benchmarks?

Mustang Bio's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Mustang Bio over the past three months?

  • November 2024: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2024: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2024: 50.00% Strong Buy, 50.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Mustang Bio’s EPS forecast?

Mustang Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-17.5, marking a 58233.33% increase from the reported $-0.03 in 2024. Estimates for the following years are $-99 in 2026, and $-51.5 in 2027.

What is Mustang Bio’s revenue forecast?

Mustang Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $11M, and $55.6M for 2027.

What is Mustang Bio’s net income forecast?

Mustang Bio's net income forecast for the fiscal year ending in December 2025 stands at $-151M, representing an 855.89% increase from the reported $-15.752M in 2024. Projections indicate $-852M in 2026, and $-443M in 2027.